Thyroid adenoma laboratory findings

Jump to navigation Jump to search

Thyroid adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thyroid adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thyroid adenoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thyroid adenoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thyroid adenoma laboratory findings

CDC on Thyroid adenoma laboratory findings

Thyroid adenoma laboratory findings in the news

Blogs on Thyroid adenoma laboratory findings

Directions to Hospitals Treating Thyroid adenoma

Risk calculators and risk factors for Thyroid adenoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of thyroid adenoma include decreased thyroid stimulating hormone, elevated calcitonin, and decreased calcium.

Laboratory Findings

  • Blood or imaging tests may be done prior to or in lieu of a biopsy. The following blood tests are conducted:[1]

Adapted from Arzu Tatlıpınar1 and İlkay Kartal [Updated 2015].The Evaluation of Thyroid Nodules. Journal of Thyroid Disorders & Therapy.2015.[2]

Laboratory tests Normal Range Abnormal value
Serum
Thyroid stimulating hormone 0.4 - 4.0 milli-international units per liter <0.4 or >4.0
Antithyroid antibodies <35 IU/mL >35 IU/mL
Serum calcitonin less than 10pg/mL >=100 pg/mL

References

  1. Bomeli SR, LeBeau SO, Ferris RL (April 2010). "Evaluation of a thyroid nodule". Otolaryngol. Clin. North Am. 43 (2): 229–38, vii. doi:10.1016/j.otc.2010.01.002. PMC 2879398. PMID 20510711.
  2. İlkay Kartal, Arzu Tatlıpınar (2014). "The Evaluation of Thyroid Nodules". Journal of Thyroid Disorders and Therapy. 04 (02). doi:10.4172/2167-7948.1000181. ISSN 2167-7948.

Template:WH Template:WS